Verastem, Inc. Restricted Cash and Cash Equivalents, Noncurrent
Verastem, Inc. (VSTM) had Restricted Cash and Cash Equivalents, Noncurrent of $241.00 thousand as of 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Balance Sheet › Assets › Assets, Noncurrent
us-gaap:RestrictedCashAndCashEquivalentsNoncurrent · last filed 2026-08-06
- 2026-06-30: Restricted Cash and Cash Equivalents, Noncurrent $241.00K.
- 2026-03-31: Restricted Cash and Cash Equivalents, Noncurrent $241.00K.
- 2025-12-31: Restricted Cash and Cash Equivalents, Noncurrent $241.00K.
- 2025-03-31: Restricted Cash and Cash Equivalents, Noncurrent $241.00K.
| Period end | Restricted Cash and Cash Equivalents, Noncurrent | Restricted Cash and Cash Equivalents, Noncurrent as first filed |
|---|---|---|
| 2026-06-30 | $241.00K 10-Q · filed 2026-08-06 | |
| 2026-03-31 | $241.00K 10-Q · filed 2026-05-07 | |
| 2025-12-31 | $241.00K 10-Q · filed 2026-08-06 | |
| 2025-03-31 | $241.00K 10-Q · filed 2025-05-13 | |
| 2024-12-31 | $241.00K 10-K · filed 2026-03-04 | |
| 2024-06-30 | $241.00K 10-Q · filed 2024-08-08 | |
| 2024-03-31 | $241.00K 10-Q · filed 2024-05-09 | |
| 2023-12-31 | $241.00K 10-K · filed 2025-03-20 | |
| 2023-09-30 | $241.00K 10-Q · filed 2023-11-08 | |
| 2023-06-30 | $241.00K 10-Q · filed 2023-08-08 | |
| 2023-03-31 | $241.00K 10-Q · filed 2023-05-09 | |
| 2022-12-31 | $241.00K 10-K · filed 2024-03-14 | |
| 2022-09-30 | $241.00K 10-Q · filed 2022-11-03 | |
| 2022-06-30 | $241.00K 10-Q · filed 2022-08-08 | |
| 2022-03-31 | $241.00K 10-Q · filed 2022-05-09 | |
| 2021-12-31 | $241.00K 10-K · filed 2023-03-14 | |
| 2021-09-30 | $241.00K 10-Q · filed 2021-11-04 | |
| 2021-06-30 | $241.00K 10-Q · filed 2021-08-02 | |
| 2021-03-31 | $241.00K 10-Q · filed 2021-05-11 | |
| 2020-12-31 | $241.00K 10-K · filed 2022-03-28 | |
| 2020-09-30 | $25.88M 10-Q · filed 2020-11-09 | |
| 2020-06-30 | $30.62M 10-Q · filed 2020-08-10 | |
| 2020-03-31 | $35.24M 10-Q · filed 2020-05-07 | |
| 2019-12-31 | $35.24M 10-K · filed 2021-03-18 | |
| 2018-12-31 | $241.00K 10-K · filed 2020-03-11 | $741.00K 10-K · filed 2019-03-12 |
| 2018-09-30 | $242.00K 10-Q · filed 2018-11-07 | |
| 2018-06-30 | $242.00K 10-Q · filed 2018-08-08 | |
| 2018-03-31 | $403.00K 10-Q · filed 2018-05-03 | |
| 2017-12-31 | $162.00K 10-K · filed 2019-03-12 | |
| 2017-09-30 | $162.00K 10-Q · filed 2017-11-07 | |
| 2017-06-30 | $162.00K 10-Q · filed 2017-08-08 | |
| 2017-03-31 | $162.00K 10-Q · filed 2017-05-10 | |
| 2016-12-31 | $162.00K 10-K · filed 2018-03-13 | |
| 2016-09-30 | $162.00K 10-Q · filed 2016-11-07 | |
| 2016-06-30 | $162.00K 10-Q · filed 2016-08-08 | |
| 2016-03-31 | $162.00K 10-Q · filed 2016-05-09 | |
| 2015-12-31 | $203.00K 10-K · filed 2017-03-23 | |
| 2015-09-30 | $203.00K 10-Q · filed 2015-11-09 | |
| 2015-06-30 | $203.00K 10-Q · filed 2015-08-10 | |
| 2015-03-31 | $203.00K 10-Q · filed 2015-05-11 | |
| 2014-12-31 | $203.00K 10-K · filed 2016-03-03 | |
| 2014-09-30 | $203.00K 10-Q · filed 2014-10-30 | |
| 2014-06-30 | $203.00K 10-Q · filed 2014-08-07 | |
| 2013-09-30 | $86.00K 10-Q · filed 2013-11-12 | |
| 2013-06-30 | $86.00K 10-Q · filed 2013-08-13 | |
| 2013-03-31 | $86.00K 10-Q · filed 2013-05-09 | |
| 2012-12-31 | $86.00K 10-K · filed 2014-03-06 | |
| 2012-09-30 | $86.00K 10-Q · filed 2012-11-13 | |
| 2012-06-30 | $86.00K 10-Q · filed 2012-08-13 | |
| 2012-03-31 | $86.00K 10-Q · filed 2012-05-14 | |
| 2011-12-31 | $86.00K 10-K · filed 2013-03-26 | |
| 2011-05-31 | $86.00K 10-K · filed 2016-03-03 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Nuvectis Pharma, Inc. (NVCT) | United States | $0.705B | -17.53 |
| IRONWOOD PHARMACEUTICALS INC (IRWD) | United States | $0.694B | 5.37 |
| Climb Bio, Inc. (CLYM) | United States | $0.683B | -13.03 |
| COLLEGIUM PHARMACEUTICAL, INC (COLL) | United States | $0.737B | 24.57 |
| ZEVRA THERAPEUTICS, INC. (ZVRA) | United States | $0.668B | 14.61 |
| Faeth Therapeutics, Inc. (FTH) | United States | $0.750B | |
| BlossomHill Therapeutics, Inc. (BLSM) | United States | $0.647B | |
| Design Therapeutics, Inc. (DSGN) | United States | $0.766B | -12.78 |
| Shattuck Labs, Inc. (STTK) | United States | $0.634B | -13.30 |
| Wave Life Sciences, Inc. (WVE) | $0.780B | -5.56 |